Archives February 2025

man, writing, laptop, computer, write, studying, working, research, study, school, notebook, business, office, work, writing, writing, laptop, computer, studying, studying, research, research, research, study, study, study, study, study, school, business, office, work, work

Semaglutide FDA Approval for Kidney Disease Risk Reduction

Articles

inflammation, kidney disease, Ozempic, semaglutide, weight loss

Semaglutide just obtained a new FDA approval aimed at addressing chronic kidney disease (CKD) in patients with Type 2 diabetes. This latest endorsement positions Ozempic as the most widely indicated

Continue readingSemaglutide FDA Approval for Kidney Disease Risk Reduction